Scalp Calcinosis in Juvenile Dermatomyositis
An observation study in Rheumatology (2021) focusing on a rare manifestation in young patients.
Dr. Upendra Rathore is a board-certified Rheumatologist and Clinical Immunologist with years of advanced training and academic excellence. He specializes in diagnosing and treating autoimmune and rheumatic diseases using a compassionate, patient-centered approach.
Research work published in top rheumatology and immunology journals
Recognized nationally for excellence in clinical research presentation

Dr. Upendra Rathore is a highly accomplished and board-certified Rheumatologist and Clinical Immunologist, committed to helping patients find lasting relief from complex autoimmune and joint disorders. With over a decade of training and clinical experience, he specializes in the diagnosis and management of conditions like rheumatoid arthritis, lupus, vasculitis, Sjögren’s syndrome, ankylosing spondylitis, and more.
Dr. Rathore earned his MBBS from LTM Medical College, Mumbai, and pursued MD in General Medicine at MGM Medical College, Indore. He further advanced his expertise with a DNB and later completed a DM in Clinical Immunology & Rheumatology from the prestigious SGPGI, Lucknow — one of India’s leading institutions in this specialty.
He has served as a Senior Resident and Assistant Professor at SGPGI, contributing not only to clinical care but also to cutting-edge research. His work has earned him numerous accolades, including the Best Oral Paper Award at IRACON 2021, and over 25 research publications in reputed international journals focused on autoimmune diseases and rheumatology.
LTM Medical College, Mumbai
MGM Medical College, Indore
National Board of Examinations
SGPGIMS, Lucknow
A Journey of Dedication and Success
Awarded at the Indian Rheumatology Association Conference (IRACON) in 2021
Received from the Korean College of Rheumatology (KCR) in 2021 to support participation.
Dr. Rathore has authored over 25 peer-reviewed research papers covering rheumatic and autoimmune diseases such as Takayasu arteritis, myositis, systemic sclerosis, and vasculitis. His work has contributed to clinical guidelines and patient care strategies in India and internationally.
An observation study in Rheumatology (2021) focusing on a rare manifestation in young patients.
A case study published in Rheumatology (Oxford) (2021) highlighting an unusual initial presentation.
An analysis of pregnancy outcomes in inflammatory myositis, systemic sclerosis, and vasculitis, published in Journal of Clinical Rheumatology and Immunology (2021).
A comparative cohort study from the MyoCite cohort, published in Rheumatology International (2021).
A protocol for a systematic review on disease-modifying antirheumatic drugs in Takayasu arteritis, published in Indian Journal of Rheumatology (2021).
A comprehensive review and meta-analysis on managing Takayasu arteritis with disease-modifying anti-rheumatic drugs, published in Clinical Rheumatology (2021).
A systematic review and meta-analysis assessing patient perspectives in Takayasu Arteritis, published in Rheumatology and Therapy (2021).
A systematic review and meta-analysis on the effectiveness of corticosteroid monotherapy for Takayasu arteritis, published in Rheumatology International (2021).
An analysis of prevalent drug usage practices in adults and children with idiopathic inflammatory myopathies from the MyoCite Cohort, published in Journal of Clinical Rheumatology (2022).
An international, two-center cohort study examining demographic, clinical, laboratory, prognostic, and treatment features of patients with antisynthetase syndrome, published in Archives of Rheumatology (2022).